Your browser doesn't support javascript.
loading
A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease.
Gonzalez-Ortiz, Fernando; Ferreira, Pamela C L; González-Escalante, Armand; Montoliu-Gaya, Laia; Ortiz-Romero, Paula; Kac, Przemyslaw R; Turton, Michael; Kvartsberg, Hlin; Ashton, Nicholas J; Zetterberg, Henrik; Harrison, Peter; Bellaver, Bruna; Povala, Guilherme; Villemagne, Victor L; Pascoal, Tharick A; Ganguli, Mary; Cohen, Anne D; Minguillon, Carolina; Contador, Jose; Suárez-Calvet, Marc; Karikari, Thomas K; Blennow, Kaj.
Afiliação
  • Gonzalez-Ortiz F; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • Ferreira PCL; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • González-Escalante A; Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Montoliu-Gaya L; Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
  • Ortiz-Romero P; Hospital del Mar Research Institute, Barcelona, Spain.
  • Kac PR; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • Turton M; Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
  • Kvartsberg H; Hospital del Mar Research Institute, Barcelona, Spain.
  • Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • Zetterberg H; Bioventix Plc, 7 Romans Business Park, Farnham, Surrey, UK.
  • Harrison P; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • Bellaver B; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Povala G; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • Villemagne VL; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Pascoal TA; King's College London, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK.
  • Ganguli M; NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, London, UK.
  • Cohen AD; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • Minguillon C; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Contador J; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.
  • Suárez-Calvet M; UK Dementia Research Institute at UCL, London, UK.
  • Karikari TK; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.
  • Blennow K; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Alzheimers Dement ; 20(2): 1239-1249, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37975513
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article